Does iron increase the risk of malaria in pregnancy

Open Forum Infectious Diseases

Volumn 2, Issue 2, 2015, Pages

  Moya Alvarez, Violeta ^a,b,c,d   Cottrell, Gilles ^a,d   Ouédraogo, Smaila ^d,e,f,g   Accrombessi, Manfred ^b,d   Massougbodgi, Achille ^h   Cot, Michel ^a,d  

^a Faculté de Pharmacie   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c EHESP SCHOOL OF PUBLIC HEALTH   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^f UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^g CENTRE HOSPITALIER UNIVERSITAIRE YALGADO OUÉDRAOGO   (Burkina Faso)

^h UNIVERSITY OF ABOMEY CALAVI   (Benin)

Author keywords

Iron levels; Pregnancy associated malaria

Indexed keywords

ALBENDAZOLE; FERROUS SULFATE; FOLIC ACID; MEFLOQUINE;

ADULT; ANEMIA; ARTICLE; CYANOCOBALAMIN DEFICIENCY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HELMINTHIASIS; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; PLACENTA MALARIA; PLASMODIUM FALCIPARUM; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SOCIOECONOMICS; YOUNG ADULT;

EID: 84978328062     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv038     Document Type: Article

References (44)

1. World Health Organization. World Malaria Report 2013. Available at: http://www.who.int/malaria/publications/world_malaria_report_2013/wmr2013_no_profiles.pdf?ua=1. Accessed 4 March 2015.
2. Maitra N, Joshi M, Hazra M. Maternal manifestations of malaria in pregnancy: a review. Indian J Matern Child Heal 1993; 4:98-101.
3. Desai M, Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7:93-104.
4. White NJ. Intermittent presumptive treatment for malaria. PLoS Med 2005; 2:e3.
5. Feng G, Simpson JA, Chaluluka E, et al. Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets. PLoS One 2010; 5:e12012.
6. Eisele TP, Larsen DA, Anglewicz PA, et al. Malaria prevention in pregnancy, birthweight, and neonatal mortality: ameta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis 2012; 12:942-9.
7. World Health Organization. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting. Malar J 2013; 12:456.
8. Harrington WE, Mutabingwa TK, Kabyemela E, et al. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis 2011; 53:224-30.
9. Maestre A, Carmona-fonseca J. Effect of submicroscopic or polyclonal Plasmodium falciparum infection on mother and gestation product: systematic review. Brazilian J Epidemiol 2010; 13:2008-9.
10. Mohammed AH, Salih MM, Elhassan EM, et al. Submicroscopic Plasmodium falciparum malaria and low birth weight in an area of unstable malaria transmission in Central Sudan. Malar J 2013; 12:1.
11. Nosten F, ter Kuile F, Maelankirri L, et al. Malaria during pregnancy in an area of unstable endemicity. Trans R Soc Trop Med Hyg 1991; 85:424-9.
12. Leenstra T, Phillips-Howard PA, Kariuki SK, et al. Permethrin-treated bed nets in the prevention of malaria and anemia in adolescent schoolgirls in western Kenya. Am J Trop Med Hyg 2003; 68:86-93.
13. Rogerson SJ, van den Broek NR, Chaluluka E, et al. Malaria and anemia in antenatal women in Blantyre, Malawi: a twelve-month survey. Am J Trop Med Hyg 2000; 62:335-40.
14. Saute F, Menendez C, Mayor A, et al. Malaria in pregnancy in rural Mozambique: the role of parity, submicroscopic and multiple Plasmodium falciparum infections. Trop Med Int Health 2002; 7:19-28.
15. Huynh BT, Fievet N, Gbaguidi G, et al. Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anemia in Benin. Am J Trop Med Hyg 2011; 85:214-20.
16. Peña-rosas JP, De-regil LM, Dowswell T, et al. Daily oral iron supplementation during pregnancy. Cochrane Collab 2012; 12:12-4.
17. Kabyemela ER, Fried M, Kurtis JD, et al. Decreased susceptibility to Plasmodium falciparuminfection in pregnant women with iron deficiency. J Infect Dis 2008; 198:163-6.
18. González R, Mombo-Ngoma G, Ouédraogo S, et al. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial. PLoS Med 2014; 11:e1001733.
19. Ouédraogo S, Koura GK, Accrombessi MM, et al. Maternal anemia at first antenatal visit: prevalence and risk factors in a malaria-endemic area in Benin. Am J Trop Med Hyg 2012; 87:418-24.
20. Ouédraogo S, Koura GK, Bodeau-Livinec F, et al. Maternal anemia in pregnancy: assessing the effect of routine preventive measures in a malaria-endemic area. Am J Trop Med Hyg 2013; 88:292-300.
21. Planche T, Krishna S, Kombila M, et al. Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg 2001; 65:599-602.
22. World Health Organization. Iron Deficiency Anaemia: Assesment, Prevention, and Control. 2001. Available at: http://www.apps.who.int/iris/bitstream/10665/66914/1/WHO_NHD_01.3.pdf?ua=1. Accessed 4 March 2015.
23. Thurnham DI, Mccabe LD, Haldar S, et al. Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a meta-analysis. Am J Clin Nutr 2010; 92:546-55.
24. Clark MA, Goheen MM, Cerami C. Influence of host iron status on Plasmodium falciparum infection. Front Pharmacol 2014; 5:84.
25. Sangaré L, van Eijk AM, Ter Kuile FO, et al. The association between malaria and iron status or supplementation in pregnancy: a systematic review and meta-analysis. PLoS One 2014; 9:e87743.
26. Joint World Health Organization/Centers for Disease Control and Technical Consultation on the Assessment of Iron Status at the Population Level. Assessing the iron status of populations. Geneva: 2004. Available at: http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9789241596107.pdf. Accessed 4 March 2015.
27. Burté F, Brown BJ, Orimadegun AE, et al. Circulatory hepcidin is associated with the anti-inflammatory response but not with iron or anemic status in childhood malaria. Blood 2013; 121:3016-22.
28. Nacher M, McGready R, Stepniewska K, et al. Haematinic treatment of anaemia increases the risk of Plasmodium vivax malaria in pregnancy. Trans R Soc Trop Med Hyg 2003; 97:273-6.
29. Le Hesran JY, Cot M, Personne P, et al. Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. Am J Trop Med Hyg 1997; 146:826-31.
30. Schwarz NG, Adegnika AA, Breitling LP, et al. Placental malaria increases malaria risk in the first 30 months of life. Clin Infect Dis 2008; 47:1017-25.
31. Tonga C, Kimbi HK, Anchang-Kimbi JK, et al. Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon. PLoS One 2013; 8:e65876.
32. Ouédraogo S, Bodeau-Livinec F, Briand V, et al. Malaria and gravidity interact to modify maternal haemoglobin concentrations during pregnancy. Malar J 2012; 11:348.
33. Van Santen S, de Mast Q, Luty AJF, et al. Iron homeostasis in mother and child during placental malaria infection. Am J Trop Med Hyg 2011; 84:148-51.
34. Senga EL, Koshy G, Brabin BJ. Zinc erythrocyte protoporphyrin as marker of malaria risk in pregnancy-a retrospective cross-sectional and longitudinal study. Malar J 2012; 11:249.
35. Menendez C, Todd J, Alonso PL, et al. The response haemoglobin to iron supplementation of pregnant women with the genotype AA or AS. Trans R Soc Trop Med Hyg 1995; 89:289-92.
36. Van Eijk AM, Ayisi JG, Slutsker L, et al. Effect of haematinic supplementation and malaria prevention on maternal anaemia and malaria in western Kenya. Trop Med Int Health 2007; 12:342-52.
37. Spottiswoode N, Duffy PE, Drakesmith H. Iron, anemia and hepcidin in malaria. Front Pharmacol 2014; 5:125.
38. Weiss G, Werner-Felmayer G, Werner ER, et al. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med 1994; 180:969-76.
39. Turner GD, Ly VC, Nguyen TH, et al. Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol 1998; 152:1477-87.
40. Kartikasari AE, Georgiou NA, Visseren FL, et al. Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron present in human sera. FASEB J 2006; 20:353-5.
41. Hurrell R. Iron and malaria: absorption, efficacy and safety. Int J Vitam Nutr Res 2010; 80:279-92.
42. Sanchez-Lopez R, Haldar K. A transferrin-independent iron uptake activity in Plasmodium falciparum-infected and uninfected erythrocytes. Mol Biochem Parasitol 1992; 55:9-20.
43. Penha-Gonçalves C, Gozzelino R, de Moraes LV. Iron overload in Plasmodium berghei-infected placenta as a pathogenesis mechanism of fetal death. Front Pharmacol 2014; 5:1-13.
44. Salcedo-Sora JE, Ward SA. The folate metabolic network of Falciparum malaria. Mol Biochem Parasitol 2013; 188:51-62.